The potential impact of FABP4 on atherosclerosis may be mainly due to value of this molecule in macrophages rather than in adipocytes, as was demonstrated by studies involving bone marrow transplantation (Rodríguez-Calvo et al., 2017). The gene discussed is FABP4; the disease is atherosclerosis.